{"title":"三角梅乙醇提取物抗糖尿病作用的评价","authors":"Chananda Saadprai , Chartchai Chaichana , Napachanok Swainson , Watip Tangjittipokin , Suttida Chukiatsiri","doi":"10.1016/j.bcab.2025.103617","DOIUrl":null,"url":null,"abstract":"<div><div><em>Bougainvillea glabra</em> is a widely decorative plant. Previous research has shown that this plant contains bioactive compounds, including phenolics and flavonoids. In this study, bracts and flowers of <em>B. glabra</em> were extracted using ethanol. Folin-Ciocalteu's and aluminum chloride colorimetric assays were used to assess the total phenolic and flavonoid contents, respectively. Anti-diabetic activities were evaluated by α-amylase and α-glucosidase inhibition assays. Glucose uptake of HepG2 hepatocytes and L6 myoblasts was studied. The level of lipid accumulation in 3T3-L1 preadipocytes were assessed. The results revealed that the ethanolic extract of <em>B. glabra</em> exhibited higher inhibition of α-amylase and α-glucosidase activity than voglibose, a positive control. It also showed the higher of glucose uptake in HepG2 and L6. Moreover, ethanolic extract of <em>B. glabra</em> showed a better reduction of lipid accumulation in 3T3-L1 when compared to positive control. The results of the GC-MS analysis showed that the ethanolic extract of <em>B. glabra</em> had a high content of secondary metabolite with anti-diabetic potential. This study showed that the ethanolic extract of <em>B. glabra</em> had anti-diabetic effects, and it could develop for anti-diabetic treatment.</div></div>","PeriodicalId":8774,"journal":{"name":"Biocatalysis and agricultural biotechnology","volume":"67 ","pages":"Article 103617"},"PeriodicalIF":3.4000,"publicationDate":"2025-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Evaluation of anti-diabetic effects of ethanolic extract of Bougainvillea glabra\",\"authors\":\"Chananda Saadprai , Chartchai Chaichana , Napachanok Swainson , Watip Tangjittipokin , Suttida Chukiatsiri\",\"doi\":\"10.1016/j.bcab.2025.103617\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div><em>Bougainvillea glabra</em> is a widely decorative plant. Previous research has shown that this plant contains bioactive compounds, including phenolics and flavonoids. In this study, bracts and flowers of <em>B. glabra</em> were extracted using ethanol. Folin-Ciocalteu's and aluminum chloride colorimetric assays were used to assess the total phenolic and flavonoid contents, respectively. Anti-diabetic activities were evaluated by α-amylase and α-glucosidase inhibition assays. Glucose uptake of HepG2 hepatocytes and L6 myoblasts was studied. The level of lipid accumulation in 3T3-L1 preadipocytes were assessed. The results revealed that the ethanolic extract of <em>B. glabra</em> exhibited higher inhibition of α-amylase and α-glucosidase activity than voglibose, a positive control. It also showed the higher of glucose uptake in HepG2 and L6. Moreover, ethanolic extract of <em>B. glabra</em> showed a better reduction of lipid accumulation in 3T3-L1 when compared to positive control. The results of the GC-MS analysis showed that the ethanolic extract of <em>B. glabra</em> had a high content of secondary metabolite with anti-diabetic potential. This study showed that the ethanolic extract of <em>B. glabra</em> had anti-diabetic effects, and it could develop for anti-diabetic treatment.</div></div>\",\"PeriodicalId\":8774,\"journal\":{\"name\":\"Biocatalysis and agricultural biotechnology\",\"volume\":\"67 \",\"pages\":\"Article 103617\"},\"PeriodicalIF\":3.4000,\"publicationDate\":\"2025-05-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Biocatalysis and agricultural biotechnology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1878818125001306\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"BIOTECHNOLOGY & APPLIED MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biocatalysis and agricultural biotechnology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1878818125001306","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
Evaluation of anti-diabetic effects of ethanolic extract of Bougainvillea glabra
Bougainvillea glabra is a widely decorative plant. Previous research has shown that this plant contains bioactive compounds, including phenolics and flavonoids. In this study, bracts and flowers of B. glabra were extracted using ethanol. Folin-Ciocalteu's and aluminum chloride colorimetric assays were used to assess the total phenolic and flavonoid contents, respectively. Anti-diabetic activities were evaluated by α-amylase and α-glucosidase inhibition assays. Glucose uptake of HepG2 hepatocytes and L6 myoblasts was studied. The level of lipid accumulation in 3T3-L1 preadipocytes were assessed. The results revealed that the ethanolic extract of B. glabra exhibited higher inhibition of α-amylase and α-glucosidase activity than voglibose, a positive control. It also showed the higher of glucose uptake in HepG2 and L6. Moreover, ethanolic extract of B. glabra showed a better reduction of lipid accumulation in 3T3-L1 when compared to positive control. The results of the GC-MS analysis showed that the ethanolic extract of B. glabra had a high content of secondary metabolite with anti-diabetic potential. This study showed that the ethanolic extract of B. glabra had anti-diabetic effects, and it could develop for anti-diabetic treatment.
期刊介绍:
Biocatalysis and Agricultural Biotechnology is the official journal of the International Society of Biocatalysis and Agricultural Biotechnology (ISBAB). The journal publishes high quality articles especially in the science and technology of biocatalysis, bioprocesses, agricultural biotechnology, biomedical biotechnology, and, if appropriate, from other related areas of biotechnology. The journal will publish peer-reviewed basic and applied research papers, authoritative reviews, and feature articles. The scope of the journal encompasses the research, industrial, and commercial aspects of biotechnology, including the areas of: biocatalysis; bioprocesses; food and agriculture; genetic engineering; molecular biology; healthcare and pharmaceuticals; biofuels; genomics; nanotechnology; environment and biodiversity; and bioremediation.